By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > QDF: Apple-Heavy Dividend Vehicle Still Does Not Appeal To Me (NYSEARCA:QDF)
News

QDF: Apple-Heavy Dividend Vehicle Still Does Not Appeal To Me (NYSEARCA:QDF)

News
Last updated: 2023/11/08 at 8:45 AM
By News
Share
11 Min Read
SHARE

Contents
QDF strategy recapThe key contributors to and detractors from QDF’s performanceFactor analysis: small EY, somewhat mediocre growthQDF could keep pace neither with IWB nor IVV; drawdown was steeperFinal thoughts

At first blush, the FlexShares Quality Dividend Index Fund ETF (NYSEARCA:QDF) is a vehicle for investors who are on the lookout for sophisticatedly calibrated dividend plays backed by high quality. And as I discussed in my note published on May 11, with QDF, they do get a solidly diversified U.S. equity basket with large exposure to the most profitable companies. Nevertheless, something that I have already addressed is that there are a few peculiarities to tolerate, like the fund’s overreliance on Apple (AAPL) and Microsoft (MSFT), which have had a 9.5% and 5.7% weight, respectively (9.4% and 6.3%, as of November 6). I have nothing against holding these tech bellwethers for dividends or dividend growth, but I believe overweighting them is unnecessary and even harmful for the yield (more on that below), and I would never allocate such a massive share of capital to them in a dividend-oriented portfolio. Partly due to that and also because of QDF’s mixed past performance and a too low yield, I struck a neutral tone.

There are a few reasons why an update is necessary today. First, since the previous note, the index the fund is tracking has been reconstituted twice (in May and August). As a consequence, close to 16% of the May portfolio has been removed, as my calculations show. Second, the ETF has lagged behind the S&P 500 index, even though it did have an exceptionally strong June and July, rising by 6.92% and 4.01%, respectively.

QDF performance since coverage

Seeking Alpha

Changes in the equity mix and price fluctuations mean there might be substantial shifts in factor exposures beneath the surface. We need to carefully review it once again to figure out whether the Hold rating should be revised higher or lower.

QDF strategy recap

According to the fund’s website, the basis of its strategy is the Northern Trust Quality Dividend Index, which represents a carefully selected group of dividend-paying constituents of the Northern Trust 1250 Index.

As described in the summary prospectus, constituents “that rank in the lowest quintile of quality based on a proprietary scoring model” are shown the red light. The said model is tripartite, encompassing management efficiency, profitability, and cash flow generation. Then, the optimization process is applied to increase quality exposure, improve the dividend yield of the mix (which should be above the yield of the parent index), and also “achieve the desired beta target.” The index is reconstituted in February, May, August, and November.

The key contributors to and detractors from QDF’s performance

As I have not been tracking the QDF portfolio since May and consequently have no data on exactly when certain holdings were added or removed, I would like to opt for analyzing only the positions that were present in the versions as of May 8 and November 6. This is an approach similar to the one I used in my bullish research note on the SPDR Russell 1000 Yield Focus ETF (ONEY) presented recently. I used prices as of May 10 and November 7.

Upon closer look, it seems that despite the fund underperforming the S&P 500, a meaningful share of the holdings that retained their place in the basket was mostly chugging along. For example, while 43 stocks saw their prices declining, with the weakest performance stories being TPR, UGI, BMY, CPT, OLN, and MAA, all with negative returns below 20%, 55 delivered gains, ranging from Illinois Tool Works’ (ITW) a few bps to NVDA’s almost 61%.

Stock Weight Sector % return
Tapestry (TPR) 0.5% Consumer Discretionary -28.3%
UGI (UGI) 0.4% Utilities -26.3%
Bristol-Myers Squibb Company (BMY) 0.1% Health Care -23.1%
Camden Property Trust (CPT) 0.5% Real Estate -21.6%
Olin (OLN) 0.5% Materials -20.8%

Created using data from Seeking Alpha and the fund

Stock Weight Sector % return
Range Resources (RRC) 0.1% Energy 33.2%
Sirius XM Holdings (SIRI) 0.4% Communication Services 37.7%
Eli Lilly and Company (LLY) 2.7% Health Care 40%
Broadcom (AVGO) 3.2% Information Technology 45.2%
NVIDIA (NVDA) 1.2% Information Technology 60.8%

To give a bit more color, one of the key reasons for Tapestry’s painful underperformance was its decision to acquire Capri Holdings (CPRI) announced in early August. While TPR’s price nosedived, CPRI immediately surged, which is typical for M&A.

Chart
Data by YCharts

This nicely illustrates that even highly selective quality-centered equity strategies like the one QDF has cannot completely immunize a portfolio from one-off events that can significantly detract from its performance.

Factor analysis: small EY, somewhat mediocre growth

QDF is still delivering on the quality side, but its value exposure has become even smaller. This does not appeal to me, especially considering a few parameters are outside my comfort range.

Metric 6-Nov 8-May
Market Cap $556.57 billion $526.76 billion
P/S 5.6 5.2
EY 4.93% 6.8%
Fwd EPS 5.99% 5.4%
Fwd Revenue 5.2% 4.5%
ROE 80.6% 48.5%
ROA 12.1% 13.1%
Quant Valuation B- or higher 13.1% 14.5%
Quant Valuation D+ or weaker 64.9% 62.4%
Quant Profitability B- or higher 92.8% 96.1%
Quant Profitability D+ or weaker 2.5% None
24M beta 0.99 0.95
60M beta 1.04 1.05

Calculated by the author using data from Seeking Alpha and the fund

  • QDF’s portfolio of 138 stocks and REITs still cannot offer sizable exposure to the value factor, as the weighted-average market cap has even risen since the previous coverage, with AAPL and MSFT being among the main contributors.
  • The earnings yield has retreated to below 5%. However, one of the key culprits is Fidelity National Information Services (FIS), which has been added since May. FIS has an EY of negative 77%.
  • The share of holdings with a Quant Valuation grade of B- or better remains too small.
  • There are only trace amounts of low-quality stocks in the basket, just 2.5%; however, in May, they were absent completely.
  • Capital efficiency is mostly robust, as illustrated by ROA. Alas, ROE is hardly a reliable metric here. One of the problems is that Home Depot (HD) had a negative ROE as of the previous note and was not taken into account. Now, its ROE is 2,065% (its massive debt is to blame), so the portfolio-wise figure is distorted.

QDF’s portfolio has a fairly small weighted average yield of just 2.6%. The fund itself has a 2.27% TTM yield.

QDF Dividend Grade

Seeking Alpha

Meanwhile, the double-digit WA dividend CAGRs look rather appealing.

Yield TTM Div Growth 3Y Div Growth 5Y
2.6% 11.3% 10.6%

Calculated by the author using data from Seeking Alpha and the fund

Nevertheless, it is worth remembering that the 3-year figure is heavily influenced by just a few stocks that are shown below. With their impact removed, the CAGR drops to 9.5%.

Stock Weight Div Growth 3Y
Cigna (CI) 0.11% 393.58%
RRC 0.58% 151.98%
Boyd Gaming (BYD) 0.07% 77.28%
Warner Music Group (WMG) 0.52% 75.62%

QDF could keep pace neither with IWB nor IVV; drawdown was steeper

Since QDF compares its performance to the Russell 1000 Index, I suppose it would be fair to look at whether it did better than the iShares Russell 1000 ETF (IWB) in the past. For more context, I also added the iShares Core S&P 500 ETF (IVV). The period analyzed is January 2013 – October 2023 (QDF was incepted in December 2012).

Portfolio QDF IVV IWB
Initial Balance $10,000 $10,000 $10,000
Final Balance $29,295 $35,964 $34,869
CAGR 10.43% 12.54% 12.22%
Stdev 14.81% 14.62% 14.80%
Best Year 36.29% 32.30% 32.78%
Worst Year -12.12% -18.16% -19.19%
Max. Drawdown -25.21% -23.93% -24.57%
Sharpe Ratio 0.67 0.81 0.78
Sortino Ratio 1.02 1.26 1.21
Market Correlation 0.97 1 1

Data from Portfolio Visualizer

Unfortunately, QDF delivered the lowest annualized return, the highest standard deviation (though marginally), and the steepest maximum drawdown.

Final thoughts

Is it worth buying into QDF for dividend growth, quality, or low volatility? Or even for all these factors at the same time? Unfortunately, I am struggling to find a sufficient reason to abandon the neutral tone and switch to a more bullish narrative for this ETF. QDF’s dividend yield is low, its value exposure is inadequate, growth characteristics are mediocre, and past performance leaves a lot to be desired, as the ETF does not offer much downside protection.

Read the full article here

News November 8, 2023 November 8, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (VLRS) M&A Call Transcript

By News
News

Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH Transcript

By News
News

Italian Confidence Ticks Up, Led By An Olympics-Driven Tourism Boost

By News
News

2026 Market Outlook: The Year Of Real Assets As AI Hype Reaches Peak

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?